US 11807689
Anti-CD20 antibody compositions
granted A61KA61K2039/545A61K47/02
Quick answer
US patent 11807689 (Anti-CD20 antibody compositions) held by TG Therapeutics, Inc. expires Mon Nov 02 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- TG Therapeutics, Inc.
- Grant date
- Tue Nov 07 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 02 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 22
- CPC classes
- A61K, A61K2039/545, A61K47/02, A61P, A61P37/00